Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT Analysis Review

Document Sample
Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					             Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT
                                       Analysis Review
        Reference Code: GDPH7691FSA                                                                                           Publication Date: MAR 2013

          780 Memorial Drive                                 Phone              +1 617 4531000                  Revenue          47.1 (million USD)
          Cambridge, MA                                      Fax                +1 617 4531001                  Net Profit       -53.96 (million USD)
          02139                                              Website            www.infi.com                    Employees        190
                                                                                                                                 Pharmaceuticals           &
          United States                                      Exchange           INFI [NASDAQ]                   Industry
                                                                                                                                 Healthcare

       Company Overview
       Infinity Pharmaceuticals, Inc. (Infinity), formerly Infinity Discovery, Inc., is a drug discovery and development company. It
       discovers, develops and delivers small molecule drugs designed to address diseases in the areas of oncology and inflammation.
       The company’s product portfolio comprises PI3K inhibitor program, Hsp90 inhibitor program and other programs. Infinity's product
       pipeline includes, retaspimycin hydrochloride, being developed to treat non-small cell lung cancer under the Hsp90 inhibitor
       program; and IPI-145, being evaluated for the treatment of hematologic malignancies and inflammatory diseases under the PI3K
       inhibitor program.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Infinity Pharmaceuticals, Inc., SWOT Analysis
         Adelene Q. Perkins                  Chairman                                 Strengths                              Weaknesses
         Martin Babler                       Director
                                                                                      Focused Research and                   Business Agreement
         Anthony B. Evnin, Ph.D.             Director                                 Development Effort                     Termination
         Eric S. Lander, Ph.D.               Director
                                                                                      Alliances and Partnerships             Business Shortcomings
         Patrick P. Lee                      Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Market Potential: Immunology           Intense Competition
         Infinity Pharmaceuticals, Inc.                                               and Pain
                                                                                                                    Stringent Government
        Share Price (USD) as on 22-Mar-                                44.98          Rising Healthcare Expenditure Regulations
        2013                                                                          in the US
        EPS (USD)                                                       -1.70
        Market Cap (million USD)                                       2,143         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                 1,974
        Shares Outstanding (million)                                       48
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Mar 05, 2013         Infinity Reports 2012 Results
                                                                                      Nov 06, 2012         Infinity Reports Q3 2012 Results
                                                                                      Aug 07, 2012         Infinity Pharma Reports Revenue Of $21.9m In
                                                                                                           Q2 2012
                                                                                      Jul 24, 2012         Infinity Pharma Appoints Lawrence Bloch As
                                                                                                           CFO
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData



       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic                                                                 Reference Code: GDPH7691FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Infinity Pharmaceuticals, Inc. - Key Facts ........................................................................................................................................... 5
       Infinity Pharmaceuticals, Inc. - Key Employees .................................................................................................................................. 6
       Infinity Pharmaceuticals, Inc. - Key Employee Biographies ................................................................................................................ 7
       Infinity Pharmaceuticals, Inc. - Major Products and Services ............................................................................................................. 8
       Infinity Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data............................................................................................. 9
          Infinity Pharmaceuticals, Inc., Pipeline Products by Therapy Area ................................................................................................. 9
          Infinity Pharmaceuticals, Inc., Pipeline Products by Development Phase..................................................................................... 10
       Infinity Pharmaceuticals, Inc. - History.............................................................................................................................................. 12
       Infinity Pharmaceuticals, Inc. - Company Statement ........................................................................................................................ 14
       Infinity Pharmaceuticals, Inc. - Locations And Subsidiaries.............................................................................................................. 20
          Head Office ................................................................................................................................................................................... 20
          Other Locations & Subsidiaries ..................................................................................................................................................... 20
       Section 2 – Company Analysis ......................................................................................................................................................... 21
       Infinity Pharmaceuticals, Inc. - Business Description ....................................................................................................................... 21
       Infinity Pharmaceuticals, Inc. - SWOT Analysis................................................................................................................................ 22
          SWOT Analysis - Overview........................................................................................................................................................... 22
          Infinity Pharmaceuticals, Inc. - Strengths ...................................................................................................................................... 22
             Strength - Focused Research and Development Effort ............................................................................................................. 22
             Strength - Alliances and Partnerships ....................................................................................................................................... 22
             Strength - Intellectual Property .................................................................................................................................................. 22
          Infinity Pharmaceuticals, Inc. - Weaknesses................................................................................................................................. 22
             Weakness - Business Agreement Termination ......................................................................................................................... 22
             Weakness - Business Shortcomings ......................................................................................................................................... 23
          Infinity Pharmaceuticals, Inc. - Opportunities ................................................................................................................................ 23
             Opportunity - Market Potential: Immunology and Pain .............................................................................................................. 23
             Opportunity - Rising Healthcare Expenditure in the US............................................................................................................. 23
             Opportunity - Market Potential: Oncology.................................................................................................................................. 23
          Infinity Pharmaceuticals, Inc. - Threats ......................................................................................................................................... 24
             Threat - Intense Competition ..................................................................................................................................................... 24
             Threat - Stringent Government Regulations .............................................................................................................................. 24
             Threat - Uncertainties in R&D ................................................................................................................................................... 24
       Infinity Pharmaceuticals, Inc. - Key Competitors .............................................................................................................................. 25
       Section 3 – Company Financial Ratios ............................................................................................................................................. 26
       Financial Ratios - Capital Market Ratios..........................................................................
				
DOCUMENT INFO
Description: Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history. Highlights Infinity Pharmaceuticals, Inc. (Infinity), formerly Infinity Discovery, Inc., is a dr
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.